ConductScience.org, home

Gene · 3609

ILF3: interleukin enhancer binding factor 3

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ILF3: interleukin enhancer binding factor 3. Genes, record 3609. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3609

On this page

Gene

Symbol
ILF3
HGNC
Name
interleukin enhancer binding factor 3
HGNC
NCBI Gene ID
3609
NCBI Gene
HGNC ID
HGNC:6038
HGNC
Ensembl
ENSG00000129351
NCBI Gene
Aliases
CBTF, DRBF, DRBP76, MMP4, MPHOSPH4, MPP4, MPP4110, NF-AT-90, NF110, NF110b, NF90, NF90a, NF90b, NF90c, NF90ctv, NFAR, NFAR-1, NFAR-2, NFAR110, NFAR2, NFAR90, TCP110, TCP80
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q12906Interleukin enhancer-binding factor 38944Ensembl, GeneID, HGNC

Source UniProt

Patents33

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1917792Q12906Espacenet
EP 4641201 A22025-10-2922035Q12906Espacenet
JP 2025517969 A2025-06-1222035Q12906Espacenet
JP 2025517970 A2025-06-1217792Q12906Espacenet
US 11446398 B22022-09-2041697Q12906Espacenet
JP 2022524081 A2022-04-27144668Q12906Espacenet
US 9878056 B22018-01-301400Q12906Espacenet
US 9874572 B22018-01-23185Q12906Espacenet
EP 3242136 A22017-11-08185Q12906Espacenet
JP 2017141230 A2017-08-175468Q12906Espacenet

1 to 10 of 33

See all 33 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,314

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleILF3 papersNewest fiscal year
ZIAAG000511Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis172025
ZIAAG000393Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging112025
P30CA047904Cancer Center Support Grant62025
P30CA008748Cancer Center Support Grant52025
R01DK057819Intestinal Mucosal Growth in Health and Surgical Diseases52025
K12CA215110YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM42025
P01CA100730Retrovirus Models of Cancer32025
P30AI027763UCSF-Bay Area Center for AIDS Research32025
P30CA016086Cancer Center Support Grant32025
P30CA016672Cancer Center Support Grant32025

1 to 10 of 1,314Source NIH's project files

See all 1,314 nih grants

Papers2,183

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer.Int J Mol Sci202642737536PubTator, text miningPubMed
[Small RNAs and ILF3 protein at the core of the coupling between aberrant mRNA decay and transcriptional adaptation].Med Sci (Paris)202642735340PubTator, text miningPubMed
ILF3 regulates erythroid differentiation: A single-cell transcriptomic analysis and cellular experiment.PLoS One202642691027PubTator, text miningPubMed
Expression Levels of DNMT1, HDAC1, and MT1E Genes as Diagnostic Biomarkers for Breast Cancer Clinicopathological Features: In Vitro and In Silico Analyses.Anal Cell Pathol (Amst)202642478333PubTator, text miningPubMed
ILF3 promotes proliferation and invasion of hepatocellular carcinoma cells through STAT3 phosphorylation and formation of an endogenous complex with SRPK1.Cell Signal202642392287PubTator, text miningPubMed
Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters.J Cardiovasc Aging202642369572PubTator, text miningPubMed
YBX1 takes actions on triggering M2-like polarization of macrophages and stabilizing CXCL8 mRNA to exhibit its metastatic potential in bladder cancer.Int Immunopharmacol202642224999PubTator, text miningPubMed
An integrative meta-analysis of SARS-CoV-2 RNA-protein interactomes identifies conserved host factors shared with other RNA viruses.Brief Funct Genomics202642149692PubTator, text miningPubMed
Functionality versus Adaptation: Insights from Transcriptional Adaptation.J Mol Evol202642133046PubTator, text miningPubMed
ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma.Hum Mutat202642063616PubTator, text miningPubMed

1 to 10 of 2,183

See all 2,183 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/3609

GET https://conductscience.org/api/genes/v1/3609/patents?page=2